Vision


OticPharma is a private clinical-stage pharmaceutical company focusing on the acquisition and development of ear, nose, and throat (ENT) products that restore health and address unmet needs in children and adults.  The company’s proprietary foam technology (OP-01) is currently being developed for acute otitis externa (“swimmers ear”) and is also being explored for the treatment of nasal and sinus conditions.  The company’s proprietary surfactant technology (OP-02) is currently being developed as a potential first-in-class, antibiotic-free treatment option for acute, recurrent, and chronic otitis media.